Susan L Koletar

Susan L Koletar

UNVERIFIED PROFILE

Are you Susan L Koletar?   Register this Author

Register author
Susan L Koletar

Susan L Koletar

Publications by authors named "Susan L Koletar"

Are you Susan L Koletar?   Register this Author

61Publications

1315Reads

22Profile Views

Screening and Enrollment by Sex in HIV Clinical Trials in the United States.

Clin Infect Dis 2019 Sep 29. Epub 2019 Sep 29.

Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciz959DOI Listing
September 2019

Association of Fibroblast Growth Factor-23 (FGF-23) With Incident Frailty in HIV-Infected and HIV-Uninfected Individuals.

J Acquir Immune Defic Syndr 2019 01;80(1):118-125

Department of Medicine, Kidney Health Research Collaborative, San Francisco VA Medical Center, University of California, San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00126334-201901010-0002
Publisher Site
http://dx.doi.org/10.1097/QAI.0000000000001868DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289864PMC
January 2019

Low thigh muscle mass is associated with coronary artery stenosis among HIV-infected and HIV-uninfected men: The Multicenter AIDS Cohort Study (MACS).

J Cardiovasc Comput Tomogr 2018 Mar - Apr;12(2):131-138. Epub 2018 Jan 31.

Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcct.2018.01.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869123PMC
August 2018

Frailty is strongly associated with increased risk of recurrent falls among older HIV-infected adults.

AIDS 2017 10;31(16):2287-2294

aHarvard T.H. Chan School of Public Health, Department of Epidemiology bHarvard T.H. Chan School of Public Health, Center for Biostatistics in AIDS Research, Boston, Massachusetts cOhio State University, Department of Internal Medicine; Columbus, Ohio dNorthwestern University Feinberg School of Medicine, Department of Medicine; Chicago, Illinois eMetroHealth and Louis Stokes Cleveland Veterans Administration Medical Center, Department of Medicine; Cleveland, Ohio fUniversity of Colorado-Anschutz Medical Campus, Department of Medicine, Aurora, Colorado, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001613DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654616PMC
October 2017

Frailty and Circulating Markers of Inflammation in HIV+ and HIV- Men in the Multicenter AIDS Cohort Study.

J Acquir Immune Defic Syndr 2017 Apr;74(4):407-417

*Johns Hopkins Bloomberg School of Public Health, Baltimore, MD;†David Geffen School of Medicine at UCLA and UCLA Fielding School of Public Health, Los Angeles, CA;‡Northwestern University Feinberg School of Medicine, Chicago, IL; and§University of Ohio School of Medicine, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001261DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365031PMC
April 2017

Long-term body composition changes in antiretroviral-treated HIV-infected individuals.

AIDS 2016 11;30(18):2805-2813

aDivision of Infectious Diseases, Department of Medicine, Stanford University, Palo Alto, California bCenter for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts cDivision of Infectious Diseases, Departments of Pediatrics and Medicine, Case Western Reserve University, Cleveland, Ohio dDivision of Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington eNew England Research Institute, Watertown, Massachusetts fDivision of Infectious Diseases, Department of Medicine, Ohio State University, Columbus, Ohio gDivision of Infectious Diseases, Department of Medicine, University of Colorado, Aurora, Colorado hDivision of Infectious Diseases, Department of Medicine, University of California Los Angeles, Los Angeles, California iDivision of Infectious Diseases, Department of Medicine, Columbia University, New York, New York jGilead Sciences, Foster City, California kViiv Healthcare, Research Triangle Park, Durham, North Carolina lDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001248DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101158PMC
November 2016

Effect of HIV-infection and cumulative viral load on age-related decline in grip strength.

AIDS 2016 11;30(17):2645-2652

aJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland bUniversity of Colorado School of Medicine, Denver, Colorado cDavid Geffen School of Medicine at UCLA, Los Angeles, California dOhio State University, Columbus, Ohio eNorthwestern University Feinberg School of Medicine, Chicago, Illinois fJohns Hopkins School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083134PMC
http://dx.doi.org/10.1097/QAD.0000000000001245DOI Listing
November 2016

Long-term Bone Mineral Density Changes in Antiretroviral-Treated HIV-Infected Individuals.

J Infect Dis 2016 08 20;214(4):607-11. Epub 2016 Jun 20.

Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiw204DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957444PMC
August 2016

Brief Report: Highly Active Antiretroviral Therapy Mitigates Liver Disease in HIV Infection.

J Acquir Immune Defic Syndr 2016 07;72(3):319-23

*Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Francisco, CA; †Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; ‡Division of Infectious Diseases, Department of Medicine, The Feinberg School of Medicine, Northwestern University, Chicago, IL; §Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles Biomedical Research Institute, Harbor-UCLA, Torrance, CA; ‖Division of Infectious Diseases, Department of Medicine, Ohio State University, Columbus, OH; and ¶Department of Medicine, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000981DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911239PMC
July 2016

The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial.

Medicine (Baltimore) 2016 Feb;95(6):e2673

From the Seattle Travel and Preventive Medicine, Seattle Infectious Disease Clinic, Seattle, WA, USA (WD); Service des Maladies Infectieuses, Hôpital Saint Antoine, Assistance Publique Hôpitaux de Paris; and INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France (P-MG); HIV Unit, Infectious Disease Service, Hospital Universitari de Bellvitge, L'Hospitalet, 08907 Barcelona, Spain (DP); Department of Dermatology, Venerology, and Allergology, St. Josef-Hospital, Ruhr-Universität Bochum, Bochum, Germany (NHB); Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain (FG); Department of Internal Medicine 3, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Germany (TH); Service d'Immunologie Clinique, Hôpital Henri Mondor, Créteil, France (J-DL); University of Pennsylvania, Philadelphia, PA, USA (IF); Service des Maladies Infectieuses et Tropicales, Hôpital Saint Louis, University of Paris Diderot Paris 7, Sorbonne Paris Cité and INSERM U941 (NCDV, J-MM); Hôpital Bichat Claude Bernard, Service des Maladies Infectieuses et Tropicales A, Paris, France (G-PY); Servicio de Enfermedades Infecciosas, Hospital General Universitario de Valencia, Valencia (EOG); Servicio de Enfermedades Infecciosas, Hospital 12 De Octubre, Madrid, Spain (RR); IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Uvic-UCC, Barcelona, Spain (BCS); Orlando Immunology Center, Orlando, FL, USA (EDS); Servicio de Enfermedades Infecciosas, Hospital Ramón Y Cajal, IRYCIS Madrid, Spain (MJPE); Université Paris Descartes, Sorbonne Paris Cité, Inserm, CIC 1417 and F-CRIN, Innovative Clinical Research Network in Vaccinology (I-REIVAC); and Assistance Publique Hôpitaux de Paris, Hôpital Cochin (OL); Maladies Infectieuses et Tropicales Co-infections, Hôpital Tenon, Paris, France (GP, JC); Saint Michael's Medical Center, Newark, NJ, USA (JS); Service d'immunologie Clinique, Hôpital Européen Georges

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000002673DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753889PMC
February 2016

Long-term impact of HIV wasting on physical function.

AIDS 2016 Jan;30(3):445-54

aUniversity of Colorado, Aurora, Colorado bJohns Hopkins University, Baltimore, Maryland cUniversity of California Los Angeles, Los Angeles, California dNorthwestern University, Chicago, Illinois eOhio State University, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000932DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712700PMC
January 2016

Accelerated Longitudinal Gait Speed Decline in HIV-Infected Older Men.

J Acquir Immune Defic Syndr 2015 Dec;70(4):370-6

*Department of Epidemiology, Johns Hopkins Bloomberg, School of Public Health, Baltimore, Maryland; †Department of Medicine, University of Colorado School of Medicine, Denver Colorado; ‡Department of Medicine, Hemtaology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California; §Division of Infectious Disease, Department of Internal Medicine, Ohio State University, Columbus, Ohio; ‖Translational Gerontology Branch, Intramural Research Program, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; ¶Division of Endocrineology and Metabolism, Internal Medicine, National Institute on Aging, National Institutes of Health, Baltimore, Maryland; and #Department of Molecular Microbiology and Immunology, Johns Hopkins School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000731DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624470PMC
December 2015

Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohort.

J Acquir Immune Defic Syndr 2014 Jun;66(2):172-80

*Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, MA; †Department of Medicine, Division of Infectious Diseases, New York University, New York, NY; ‡Division of Infectious Diseases, Ohio State University, Columbus, OH; and §Department of Epidemiology and Biostatistics, George Washington University Milken Institute, School of Public Health, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000149DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169110PMC
June 2014

Safety of varenicline among smokers enrolled in the lung HIV study.

Nicotine Tob Res 2013 Jan 15;15(1):247-54. Epub 2012 May 15.

College of Public Health, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ntr/nts121DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524069PMC
January 2013

Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patients.

BMC Med Genomics 2012 Jul 23;5:32. Epub 2012 Jul 23.

Department of Pharmacology, Program in Pharmacogenomics, School of Biomedical Science, College of Medicine, Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1755-8794-5-32DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418550PMC
July 2012

HIV and asthma, is there an association?

Respir Med 2012 Apr 27;106(4):493-9. Epub 2012 Jan 27.

The Ohio State University, Department of Internal Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, 201 Davis Heart & Lung Research Institute, 473 West 12th Avenue, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235227PMC
http://dx.doi.org/10.1016/j.rmed.2011.12.017DOI Listing
April 2012

Human N-acetyltransferase 1 *10 and *11 alleles increase protein expression through distinct mechanisms and associate with sulfamethoxazole-induced hypersensitivity.

Pharmacogenet Genomics 2011 Oct;21(10):652-64

Department of Pharmacology, Program in Pharmacogenomics, School of Biomedical Science, Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0b013e3283498ee9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172334PMC
October 2011

Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients.

AIDS 2009 Oct;23(16):2133-41

University of Hawaii, John A. Burns School of Medicine, Hawaii AIDS Clinical Research Program, 3675 Kilauea Avenue, 5th Floor, Young Building, Honolulu, HI 96816, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0b013e32833068e3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782438PMC
October 2009

AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics.

HIV Clin Trials 2008 Jul-Aug;9(4):269-82

Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1310/hct0904-269DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704053PMC
October 2008

Third-trimester maternal toxicity with nevirapine use in pregnancy.

Obstet Gynecol 2005 Nov;106(5 Pt 1):1032-8

Department of Obstetrics and Gynecology, College of Medicine, Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/greenjournal/2005/11000/Third_T
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/01.AOG.0000180182.00072.e3DOI Listing
November 2005

Long-term follow-up of HIV-infected individuals who have significant increases in CD4+ cell counts during antiretroviral therapy.

Clin Infect Dis 2004 Nov 22;39(10):1500-6. Epub 2004 Oct 22.

Division of Infectious Diseases, Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/424882DOI Listing
November 2004

Localized osteomyelitis due to Mycobacterium avium complex in patients with Human Immunodeficiency Virus receiving highly active antiretroviral therapy.

Clin Infect Dis 2002 Jul 4;35(1):E8-E13. Epub 2002 Jun 4.

Department of Medicine, Washington University School of Medicine, AIDS Clinical Trials Unit, St. Louis, MO, 63108, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/340714DOI Listing
July 2002

Prevalence of fluconazole-resistant strains of Candida albicans in otherwise healthy outpatients.

J Oral Pathol Med 2002 Feb;31(2):99-105

Section of Oral Maxillofacial and Pathology, Temple University School of Dentistry, Philadelphia, Pennsylvania 19140, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1034/j.1600-0714.2002.310207.xDOI Listing
February 2002